1. Whiteman D, Green A: Melanoma and sunburn. Cancer Causes & Control 5(6):564-572, 1994.
2. Lober CW, Fenske NA: Photoaging and the skin: differentiation and clinical response. Geriatrics 45(4):36-40, 42, 1990.
3. Taylor CR, Stern RS, Leyden JJ, et al.: Photoaging/photodamage and photoprotection. J Amer Acad Dermatol 22(1):1-15, 1990.
4. Young AR: Cumulative effects of ultraviolet radiation on the skin: cancer and photoaging. Seminars in Dermatology 9(1):25-31, 1990.
5. Chase M, Tan worshippers may be giving skin lots more than glow, in Wall Street Journal. 1995, New York. p. pp.B1.
6. Environmental Health Criteria 160: Ultraviolet Radiation. Environmental Health Criteria, ed. WHO. 1994, Vammala, Finland: World Health Organization. 352.
7. Lydahl E, Philipson B: Infrared radiation and cataract. I. Epidemiologic investigation of iron- and steel-workers. Acta Ophthalmologica 62(6):961-975, 1984.
8. Lydahl E: Infrared radiation and cataract. Acta Ophthalmologica - Supplementum 166:1-63, 1984.
9. Lydahl E, Philipson B: Infrared radiation and cataract II. Epidemiologic investigation of glass workers. Acta Ophthalmologica 62(6):976-992, 1984.
10. Jones CS, Tyring SK, Lee PC, et al.: Development of neuroendocrine (Merkel cell) carcinoma mixed with squamous cell carcinoma in erythema ab igne. Arch Dermatol 124(1):110-113, 1988.
11. Akasaka T, Kon S: [Two cases of squamous cell carcinoma arising from erythema ab igne]. Nippon Hifuka Gakkai Zasshi - Japanese Journal of Dermatology 99(6):735-742, 1989.
12. Arrington JHd, Lockman DS: Thermal keratoses and squamous cell carcinoma in situ associated with erythema ab igne. Arch Dermatol 115(10):1226-1228, 1979.
13. Kligman LH: Intensification of ultraviolet-induced dermal damage by infrared radiation. Arch Dermatol Res 272(3-4):229-238, 1982.
14. Kligman LH: Retinoic acid and photocarcinogenesis--a controversy. Photo-Dermatology 4(2):88-101, 1987.
15. Kligman LH: Photoaging. Manifestations, prevention, and treatment. Dermatologic Clinics 4(3):517-528, 1986.
16. Sams WMJ: Sun-induced aging. Clinical and laboratory observations in humans. Clinics in Geriatric Medicine 5(1):223-233, 1989.
17. Griffiths CE: The clinical identification and quantification of photodamage. Br J Dermatol 127(Suppl 41):37-42, 1992.
18. Lowe NJ, Meyers DP, wieder JM, et al.: Low doses of repetitive ultraviolet A induce morphologic changes in human skin. J Invest Dermatol 105(6):739-743, 1995.
19. Lavker RM, gerberick GF, Veres D, et al.: Cumulative effects from repeated exposure to suberythemal doses of UVB and UVA in human skin. J Amer Acad Dermatol 32(1):53-62, 1995.
20. Robinson ES, VandeBerg JL, Hubbard GB, et al.: Malignant melanoma in ultraviolet irradiated laboratory opossums: initiation in suckling young, metastasis in adults, and xenograft behavior in nude mice. Cancer Res 54(22):5986-5991, 1994.
21. Maenpaa J, Dooley T, Wurz G, et al.: Topical toremifene: a new approach for cutaneous melanoma? Cancer Chemotherapy & Pharmacology 32(5):392-395, 1993.
22. Kusewitt DF, Applegate LA, Bucana CD, et al.: Naturally occurring malignant melanoma in the South American opossum (Monodelphis domestica). Vet Pathol 27(1):66-68, 1990.
23. Shea CR, Parrish JA, Nonionizing radiation and the skin, in Physiology, biochemistry, and molecular biology of the skin, L.A. Goldsmith, Editor. 1991, Oxford University Press: New York. p. 910-927.
24. Pence BC, Naylor MF: Effects of single-dose ultraviolet radiation on skin superoxide dismutase, catalase, and xanthine oxidase in hairless mice. J Invest Dermatol 95(2):213-216, 1990.
25. Parlar H: Excited-state controlled peroxide formation of DNA. Ecotoxicology & Environmental Safety 10(1):120-127, 1985.
26. Youn JI, Gange RW, Maytum D, et al.: Effect of hypoxia on sunburn cell formation and inflammation induced by ultraviolet radiation. Photo-Dermatology 5(6):252-256, 1988.
27. Roshchupkin DI, Pistsov MY, Potapenko AY: Inhibition of ultraviolet light-induced erythema by antioxidants. Arch Dermatol Res 266(1):91-94, 1979.
28. Youssefi AA, Arutyunyan R, Emerit I: Chromosome damage in PUVA-treated human lymphocytes is related to active oxygen species and clastogenic factors. Mutation Res 309(2):185-191, 1994.
29. Stewart MS, Cameron GS, Pence BC: Antioxidant nutrients protect against UVB-induced oxidative damage to DNA of mouse keratinocytes in culture. J Invest Dermatol in press, 1996.
30. Andersen PH, Abrams K, Bjerring P, et al.: A time-correlation study of ultraviolet B-induced erythema measured by reflectance spectroscopy and laser Doppler flowmetry. Photodermatology, Photoimmunology & Photomedicine 8(3):123-128, 1991.
31. Ramsay CA, A.V. C: Vascular changes in human skin after ultraviolet irradiation. Br J Dermatol 94(5):487-493, 1976.
32. Hruza LL, Pentland AP: Mechanisms of UV-induced inflammation. Journal of Investigative Dermatology. 100 1(35S-41S):Jan., 1993.
33. Snyder D: Cutaneous effects of topical indomethacin, an inhibitor of prostaglandin synthesis, on UV-damaged skin. J Invest Dermatol 64(5):322-325, 1975.
34. Thiele B, Ghyczy M, Lunow C, et al.: Influence of phospholipid liposomes (PLL) on UVB-induced erythema formation. Arch Dermatol Res 285(7):428-431, 1993.
35. Law E, Lewis AJ: The effect of systemically and topically applied drugs on ultraviolet-induced erythema in the rat. British Journal of Pharmacology 59(4):591-597, 1977.
36. Plummer NA, Hensby CN, Greaves MW, et al.: Inflammation in human skin induced by ultraviolet irradiation. Postgraduate Medical Journal 53(625):656-657, 1977.
37. Gomez EC, Trancik RJ: Effect of topical diflumidone on ultraviolet-light-induced erythema. Dermatologica 162(3):175-182, 1981.
38. Adams SS, Humphries RG, Mason CG: The relationship between development of ultraviolet erythema and release of prostaglandins in guinea pig skin. Agents & Actions 11(5):473-476, 1981.
39. Chung JH, Youn JI: Effect of ultraviolet A on IL-1 production by ultraviolet B in cultured human keratinocytes. Journal of Dermatological Science 9(2):87-93, 1995.
40. Camp R, Fincham N, Ross J, et al.: Potent inflammatory properties in human skin of interleukin-1 alpha-like material isolated from normal skin. J Invest Dermatol 94(6):735-741, 1990.
41. Dowd PM, Camp RD, Greaves MW: Human recombinant interleukin-1 alpha is proinflammatory in normal human skin. Skin Pharmacology 1(1):30-37, 1988.
42. Bonifati C, Carducci M, Cordiali Fei P, et al.: Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients--relationships with disease severity. Clinical & Experimental Dermatology 19(5):383-387, 1994.
43. Bonifati C, Ameglio F, Carducci M, et al.: Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninolved skin and in sera of psoriatic patients. Acta Dermato-Venereologica 186 Supplementum(23-24), 1994.
44. Akiyama M, Yokoyama M, Katsuki M, et al.: Lymphocyte infiltration of the skin in transgenic mice carrying the human interleukin-2 gene. Arch Dermatol Res 285(7):379-384, 1993.
45. Larbre B, Nicolas JF, Sarret Y, et al.: [Interleukin-2 immunotherapy and cutaneous manifestations]. Annales de Dermatologie et de Venereologie 120(8):528-533, 1993.
46. Wolkenstein P, Chosidow O, Wechsler J, et al.: Cutaneous side effects associated with interleukin 2 administration for metastatic melanoma. J Amer Acad Dermatol 28(1):66-70, 1993.
47. Vial T, Descotes J: Clinical toxicity of interleukin-2. Drug Safety 7(6):417-433, 1992.
48. Robak T: [Biological properties and clinical applications of interferon gamma (IFN-gamma)]. Acta Haematologica Polonica 25(1):19-29, 1994.
49. SivaSai KS, Prasad HK, Misra RS, et al.: Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients. International Journal of Leprosy & Other Mycobacterial Diseases 61(2):259-269, 1993.
50. Todd PA, Goa KL: Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease. Drugs 43(1):111-122, 1992.
51. Bolinger AM, Taeubel MA: Recombinant interferon gamma for treatment of chronic granulomatous disease and other disorders. Clinical Pharmacy 11(10):834-850, 1992.
52. Grunberg SM, Kempf RA, Venturi CL, et al.: Phase I study of recombinant beta-interferon given by four-hour infusion. Cancer Res 47(4):1174-1178, 1987.
53. Muranaka M, Suzuki S: Studies on safety problem by skin tests using human beta interferon preparation. Journal of Interferon Research 4(1):115-122, 1984.
54. Eaglstein WH, Sakai M, Mizuno N: Ultraviolet radiation-induced inflammation and leukocytes. J Invest Dermatol 72(2):59-63, 1979.
55. Murphy GM, Dowd PM, Hudspith BN, et al.: Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo. Photo-Dermatology 6(6):268-274, 1989.
56. Hacham H, Freeman SE, Gange RW, et al.: Do pyrimidine dimer yields correlate with erythema induction in human skin irradiated in situ with ultraviolet light (275-365 nm)? Photochemistry & Photobiology 53(4):559-563, 1991.
57. Green AC, Siskind V, Bain C, et al.: Sunburn and malignant melanoma. Br J Cancer 51(3):393-397, 1985.
58. Westerdahl J, Olsson H, Ingvar C: At what age do sunburn episodes play a crucial role for the development of malignant melanoma. Eur J Cancer 30A(11):1647-1654, 1994.
59. Nelemans PJ, Groenendal H, Kiemeney LA, et al.: Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 101(3):252-255, 1993.
60. MacKie RM, Aitchison T: Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 40(6):955-960, 1982.
61. Holly EA, Aston DA, Cress RD, et al.: Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. American Journal of Epidemiology 141(10):923-933, 1995.
62. Dunn-Lane J, Herity B, Moriarty MJ, et al.: A case control study of malignant melanoma. Irish Medical Journal 86(2):57-59, 1993.
63. Grodstein F, Speizer FE, Hunter DJ: A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study. J Natl Cancer Inst 87(14):1061-1066, 1995.
64. Kricker A, Armstrong BK, English DR, et al.: Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer 60(4):489-494, 1995.
65. Gallagher RP, Hill GB, Bajdik CD, et al.: Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 131(2):157-163, 1995.
66. Kelfkens G, van Weelden H, de Gruijl FR, et al.: The influence of dose rate on ultraviolet tumorigenesis. Journal of Photochemistry & Photobiology. B - Biology 10(1-2):41-50, 1991.
67. Bissett DL, Majeti S, Fu JJ, et al.: Protective effect of topically applied conjugated hexadienes against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatology, Photoimmunology & Photomedicine 7(2):63-67, 1990.
68. van Weelden H, van der Putte SC, Toonstra J, et al.: UVA-induced tumours in pigmented hairless mice and the carcinogenic risks of tanning with UVA. Arch Dermatol Res 282(5):289-294, 1990.
69. Gallagher CH, Canfield PJ, Greenoak GE, et al.: Characterization and histogenesis of tumors in the hairless mouse produced by low-dosage incremental ultraviolet radiation. J Invest Dermatol 83(3):169-174, 1984.
70. Leyden JJ: Clinical features of ageing skin. Br J Dermatol 122(Suppl 35):1-3, 1990.
71. Richard S, de Rigal J, de Lacharriere O, et al.: Noninvasive measurement of the effect of lifetime exposure to the sun on the aged skin. Photodermatology, Photoimmunology & Photomedicine 10(4):164-169, 1994.
72. Green A: Premature ageing of the skin in a Queensland population. Medical Journal of Australia 155(7):473-474, 477-8, 1991.
73. Ortonne JP: Pigmentary changes of the ageing skin. Br J Dermatol 122(Suppl 35):21-28, 1990.
74. Goh SH: The treatment of visible signs of senescence: the Asian experience. Br J Dermatol 122(Suppl 35):105-109, 1990.
75. Holzle E: Pigmented lesions as a sign of photodamage. Br J Dermatol 127(Suppl 41):48-50, 1992.
76. Fourtanier A, Labat-Robert J, Kern P, et al.: In vivo evaluation of photoprotection against chronic ultraviolet-A irradiation by a new sunscreen Mexoryl SX. Photochemistry & Photobiology 55(4):549-560, 1992.
77. Roberts MA, Andrews GR, Caird FI: Skinfold thickness on the dorsum of the hand in the elderly. Age & Ageing 4(1):8-15, 1975.
78. Feinstein RJ, Halprin KM, Penneys NS, et al.: Senile purpura. Arch Dermatol 108(2):229-232, 1973.
79. Kiss I, Chen S, Tramposch KM: The effect of high and low ultraviolet-B dose exposure on the degree of hairless mouse skin wrinkling. Photochemistry & Photobiology 53(1):109-112, 1991.
80. Noonan FP, De F, E.C., Kripke ML: Suppression of contact hypersensitivity by UV radiation and its relationship to UV-induced suppression of tumor immunity. Photochemistry & Photobiology 34(6):683-689, 1981.